SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (13099)1/8/1998 5:09:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Andy, I think that the cataracts refer to retinoids in general, but I have to check.

I suspect that the skin cancer was not CTCL. I think that Targretin is being used "ccompasionately" for a variety of malignancies that have not yet been targeted. Earlier I posted on a patient with Stage IV melanoma, which is another example.

I was looking for my cheat sheet. I thought that Targretin or Panretin was being tested on skin cancer patients.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News